By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
CTN News-Chiang Rai TimesCTN News-Chiang Rai TimesCTN News-Chiang Rai Times
  • Home
  • Chiang Rai News
  • News
    • Crime
    • Northern Thailand
    • Southern Thailand
    • News Asia
    • India
    • China
    • World News
  • Business
    • Sponsored
    • PR News
  • Entertainment
    • Lifestyles
  • Health
  • Politics
  • Social Media
  • Sports
  • Tech
  • Weather
Reading: Doctors Start Lutetium 177 PSMA Therapy in Germany
Share
Notification Show More
Font ResizerAa
CTN News-Chiang Rai TimesCTN News-Chiang Rai Times
Font ResizerAa
  • Chiang Rai News
  • Regonal News
  • Politics
  • Northern Thailand
  • Crime
  • Business
  • Sports
  • Weather
  • Home
  • Chiang Rai News
  • News
    • Crime
    • Northern Thailand
    • Southern Thailand
    • News Asia
    • India
    • China
    • World News
  • Business
    • Sponsored
    • PR News
  • Entertainment
    • Lifestyles
  • Health
  • Politics
  • Social Media
  • Sports
  • Tech
  • Weather
Follow US
  • Advertise
  • Advertise
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
CTN News-Chiang Rai Times > Health > Doctors Start Lutetium 177 PSMA Therapy in Germany
Health

Doctors Start Lutetium 177 PSMA Therapy in Germany

PR News
Last updated: May 21, 2025 5:13 am
PR News
2 months ago
Share
Lutetium 177 PSMA Therapy
SHARE

BERLIN – End-stage cancer is difficult to treat because it spreads throughout the body. Multiple metastases appear, including those that cannot be detected due to their small size.

It is impossible to remove or irradiate all metastases, and therefore, at stage 4, mainly systemic treatment methods are used, which affect all malignant foci in the body. Traditionally, hormone therapy and chemotherapy have been considered the main treatment methods for stage 4 prostate cancer, but sooner or later, there comes a point when they stop working.

Lutetium 177 PSMA therapy in Germany then allows doctors to succeed even in the most severe cases: advanced stages and aggressive prostate tumours that do not respond to other treatment methods.

The essence of Lutetium 177 PSMA therapy

PSMA therapy is one of the types of radiotargeted therapy. It is aimed at the radioactive destruction of all tumors in the body. Doctors use a drug that accumulates in tumor cells and affects them with beta radiation.

Radiotargeted therapy is aimed at a molecular target, that is, PSMA (prostate-specific membrane antigen). It is abundant in cancer cells, but PSMA is almost absent in healthy tissues outside the prostate. That is why the drug accumulates only in tumors and not in healthy tissues.

The drug contains two types of molecules: ligands that are able to bind to PSMA and the radionuclide Lutetium 177, which is a source of radiation. It releases radiation for several days and is then excreted from the patient’s body.

The radiation that Lutetium 177 gives is very short, so the radiation practically does not spread beyond the tumor. That is why therapy rarely causes any severe complications and is well tolerated by most patients. The most common side effect of Lutetium therapy is dry mouth, because a small amount of PSMA is found in the salivary glands.

How is Lutetium 177 treatment carried out?

The treatment cycle involves a single intravenous administration of the radiopharmaceutical agent. A person then spends several days in the hospital until the radioactive material is eliminated from the body.

Treatment courses are repeated once every 4-8 weeks. Following every two cycles, PSMA-PET diagnostics are carried out to assess how well the cancer treatment is working.

Most patients receive an objective response (tumor shrinkage by more than a third) after the first injection of the radiopharmaceutical agent. After several injections, a long-term remission is achieved. In some patients, prostate cancer treatment with Lutetium leads to the complete disappearance of all tumors.

The medical literature describes cases where the cancer did not return for many years upon the completion of treatment. It is possible that in some treated patients the cancer will never recur as a result of Lutetium’s destruction of all malignant cells.

Where to undergo Lutetium 177 treatment for prostate cancer?

You are welcome to visit the Booking Health website, if you want to undergo your Lutetium 177 treatment in Germany. Our website lists the best German clinics offering Lutetium treatment. You can find out the cost of medical services, compare prices, and make your treatment appointment at a favorable price.

You are welcome to leave your request on our website to get a consultation. The Booking Health specialists will contact you, help you select a clinic, and answer any questions that may arise. The medical tourism agency Booking Health will take care of all the arrangements for your trip abroad for treatment and will provide assistance in resolving any issues during the entire period of your stay in Germany.

Related Health News:

A Study Shows that Breast Cancer Treatment Strains Finances.

 

TAGGED:Lutetium 177PSMA therapy
Share This Article
Facebook Email Print
ByPR News
The opinions or information expressed in this article are solely those of the authors and do not necessarily reflect the views of the Chiang Rai Times. For more information on our sponsored content policy, Click Here
Previous Article Capital One Capital One Has Acquired Discover. Here’s What It Means For Them.
Next Article Understanding a VPN and Why You Should Use One Understanding a VPN and Why You Should Use One

SOi Dog FOundation

Trending News

Police Catch Two in a Late Night Drug Haul Operation
Police Catch Two in a Late Night Drug Haul Operation
Crime
Aga Khan University, Dr Zulfiqar A. Bhutta
Aga Khan University Awards Dr Zulfiqar A. Bhutta the Prestigious Virchow Prize
PR News
JPMorgan
JPMorgan Posts Strong Second Quarter Numbers Despite Tariff and Geopolitical Risks
News
Nvidia
Nvidia Will Ship H20 Chips to China Again After the US Grants an Export License.
Tech

Make Optimized Content in Minutes

rightblogger

Download Our App

ctn dark

The Chiang Rai Times was launched in 2007 as Communi Thai a print magazine that was published monthly on stories and events in Chiang Rai City.

About Us

  • CTN News Journalist
  • Contact US
  • Download Our App
  • About CTN News

Policy

  • Cookie Policy
  • CTN Privacy Policy
  • Our Advertising Policy
  • Advertising Disclaimer

Top Categories

  • News
  • Crime
  • Chiang Rai News
  • Northern Thailand

Find Us on Social Media

Copyright © 2025 CTN News Media Inc.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?